Trademark: 98035730
Word
EUCODIS
Status
Registered
Status Code
700
Status Date
Tuesday, December 5, 2023
Serial Number
98035730
Registration Number
7236632
Registration Date
Tuesday, December 5, 2023
Mark Type
4000
Filing Date
Friday, June 9, 2023
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Biosynth AG - Original Registrant

Classifications
5 Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
1 Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms

Trademark Events
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Dec 5, 2023
Registered-Principal Register
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2023
Published For Opposition
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Aug 11, 2023
Approved For Pub - Principal Register
Aug 9, 2023
Assigned To Examiner
Jul 13, 2023
New Application Office Supplied Data Entered
Jun 13, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24